جست‌وجوی استاد و پژوهشگر

• Microbiology
• Infection Biology
• Antimicrobial Resistance
• +۵ مورد دیگر

Bernhard Krismer is a Researcher at the Department of Microbiology and Infection Medicine within the Faculty of Mathematics and Natural Sciences at the University of Tübingen . He holds a PhD in Microbiology and has a background in Biology, studied in Innsbruck and Tübingen. Since 2008, he has been a key member of Prof. Andreas Peschel's group, focusing on the ecology of Staphylococcus aureus nasal colonization and development of anti-infectives. PhD in Microbiology Postdoctoral training in Friedrich Götz's Tübingen lab His research explores Staphylococcal nasal colonization , antimicrobial biosynthesis , and host-microbe interactions , including the role of metabolite profiles, methionine biosynthesis as a drug target, and synthetic nasal media. He investigates microbiome-shaping bacteriocins , lugdunin's immunomodulatory effects , and genetic mechanisms of microbial competition . Recent publications highlight antimicrobial peptides , gene regulation , and metabolic adaptations in staphylococcal species. His affiliations include the Cluster of Excellence CMFI and the German Center for Infection Research (DZIF) , where he contributes to projects targeting hospital-associated and antibiotic-resistant infections . He supervises a research team with PhD students Ahmed MA Elsherbini, Jens Mössner, Lukas Schulze, and Master's student Jenny Weigand.

Balaraman Kalyanaramanمشاهده پروفایل

استاد

• Oxidative Stress
• Mitochondrial Biology
• Cancer Biology
• +۴ مورد دیگر

Balaraman Kalyanaraman is the Harry R. & Angeline E. Quadracci Professor in Parkinson’s Research at the Medical College of Wisconsin (MCW), Department of Biophysics. He joined MCW in 1981 as a research associate and became faculty in 1984. He served as Director of the Biophysics Research Institute (2000–2003) and Chair of the Department of Biophysics (2003–2022). His academic credentials include a BS (Loyola College, India), MS (IIT Mumbai), PhD (University of Alabama), and postdoctoral training at the National Institute of Environmental Sciences and MCW’s EPR Center. His research focuses on oxidative stress mechanisms in cancer, neurodegeneration, and chemotherapeutic toxicity, with emphasis on mitochondrial targeting strategies. Key areas include mitochondrially targeted drugs for cancer and Parkinson’s disease, redox signaling in tumor biology, and gut microbiome interactions in neurodegenerative disorders. His lab develops novel probes for reactive species detection and investigates metabolic modulation in cancer therapy. Notable contributions include studies on Mito-LON and Mito-HNK for lung cancer treatment, mitochondrial drug delivery systems, and the role of short-chain fatty acids in Parkinson’s pathogenesis. He has authored over 12 papers in 2023–2025, primarily in Redox Biology, Cancer Communications , and Free Radical Biology and Medicine . Editorial roles include associate editorships for Free Radicals in Biology and Medicine and Free Radical Research . Current lab members include Gang Cheng, Assistant Professor. Research is supported by grants exploring mitochondrial therapeutics in oncology and neuroprotection. Key facilities include the MCW Biophysics Department and collaborations with institutions like the National Institute of Environmental Sciences. Future directions emphasize translational applications of mitochondrial-targeted agents and gut microbiome-based therapies.

• Immune Tolerance
• Autoimmune Diseases
• Lupus Nephritis
• +۴ مورد دیگر

Dawn Smilek, MD, PhD, is a Professor at the Diabetes Center within the School of Medicine at the University of California, San Francisco (UCSF). Her research focuses on immune tolerance mechanisms, autoimmune diseases such as lupus nephritis and multiple sclerosis, and the development of novel immunotherapies. She is particularly known for her work on immunosuppressive agents like abatacept and their effects on T cell subsets and immune pathways. Dr. Smilek’s work spans clinical trials investigating treatments for psoriasis and lupus nephritis, as well as translational studies on the immune cell landscape in autoimmune conditions. Her research interests include the dynamics of anti-nuclear antibodies in systemic lupus erythematosus (SLE), the role of microbiota in immune regulation, and the application of gene and cellular therapies for autoimmune diseases. She collaborates with co-authors such as Wofsy, Dall’Era, and Zamvil on projects addressing immune system diseases and therapeutic strategies. Dr. Smilek’s publications highlight advancements in understanding immunological pathways, including studies on T follicular helper cells and regulatory T cells, as well as the molecular mechanisms underlying lupus nephritis and psoriasis. Her clinical contributions include pivotal trials like ACCLAIM (abatacept in multiple sclerosis) and PAUSE (ustekinumab withdrawal in psoriasis). Her academic affiliation with the Diabetes Center underscores her interdisciplinary approach to autoimmune research, bridging immunology, nephrology, and dermatology.

Eric C. Martensمشاهده پروفایل

استاد

• Microbial Metabolism
• Gut Microbiome
• Inflammatory Bowel Disease
• +۶ مورد دیگر

Eric C. Martens is a Professor of Microbiology and Immunology at the University of Michigan Medical School. His research focuses on the role of human gut microbiota in metabolizing complex carbohydrates and their implications in inflammatory diseases. He leads the Martens Lab and is a Center Member at the Rogel Cancer Center. Education: PhD in Microbiology from the University of Wisconsin (2005); BA in Biology from Washington University (1997). Research interests include microbial carbohydrate metabolism, host-microbe interactions in inflammatory bowel disease (IBD), and microbiome-driven therapeutic strategies. His lab investigates how gut bacteria degrade mucin glycans and dietary fibers, with recent studies on symbiotic species like Bacteroides and Ruminococcus torques . Recent publications highlight mechanisms linking diet, microbiota composition, and disease susceptibility. Key findings include the role of Eubacterium rectale in low-fiber diets and Bacteroides ovatus in mitigating graft-versus-host disease. His work integrates genomic evolution studies of gut bacteria, phage interactions, and microbial community assembly. Collaborations span microbiology, immunology, and translational medicine to develop diet-based therapies for intestinal health. Labs/Teams: Martens Lab (focusing on microbiome-metabolism-disease interfaces). Notable lab member: Qinnan Yang (postdoctoral researcher).

• Paediatric Inflammatory Bowel Disease
• Microbiome in IBD
• Clinical Outcomes Research
• +۴ مورد دیگر

Seamus Hussey is a Clinical Senior Lecturer at the Royal College of Surgeons in Ireland (RCSI), Department of Paediatrics and Child Health. He is also a Consultant Paediatric Gastroenterologist at Our Lady’s Children’s Hospital, Crumlin, Dublin. His primary research focus is on paediatric inflammatory bowel disease (IBD), particularly the microbiome in IBD, clinical outcomes, and novel therapeutic strategies. He leads the DOCHAS project (Determinants and Outcomes in Children and Adolescents with IBD) at the National Children’s Research Centre. Prof. Hussey is an elected member of the Porto IBD Group of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). His research interests include paediatric IBD epidemiology, host-microbial interactions, and translational therapies. He collaborates internationally on projects related to IBD pathogenesis and treatment efficacy. His recent publications highlight advancements in understanding IBD mechanisms, including neutrophil subsets’ role in intestinal disease and the impact of anti-TNF therapy in obese children with IBD. Prof. Hussey has secured grants for projects such as 'Engineered recombinant activated protein C as a novel therapeutic agent for children with IBD' and 'Outcomes of Modified Exclusive Elemental Nutrition in Paediatric Crohn’s Disease.' He is actively involved in clinical training, supervising Specialist Paediatric Registrar Trainees since 2015. Professional roles include Clinical Lead in Paediatric Gastroenterology and membership in the National Endoscopy Clinical Advisory Group. His work aligns with UN Sustainable Development Goal 3 (Good Health and Well-Being), focusing on improving paediatric gastrointestinal health outcomes globally.

David B Corryمشاهده پروفایل

استاد

• Allergy
• Immunology
• Asthma
• +۵ مورد دیگر

David B Corry, M.D., is a Professor and Fulbright Endowed Chair in Pathology at Baylor College of Medicine, Houston, Texas. He holds positions in the Departments of Medicine and Pathology & Immunology, with affiliations at the Michael E. DeBakey VA Medical Center and the Dan L Duncan Comprehensive Cancer Center. His research focuses on immunology, allergy, asthma mechanisms, fungal pathogenesis, and autoimmune diseases linked to chronic obstructive pulmonary disease (COPD) and emphysema. Education: M.D. from University of Texas Southwestern Medical School (1988), followed by residency and fellowship training in pulmonary and critical care medicine at Duke University and University of California, San Francisco. Certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine by the American Board of Internal Medicine. Research Interests: Investigates T cell biology, airway physiology, proteases in immunity, fungal infections (e.g., Candida albicans), and Alzheimer’s disease pathophysiology. Develops therapies targeting allergic responses, autoimmunity, and lung inflammation. Key contributions include linking fungal proteases to asthma exacerbations and identifying autoimmunity in cigarette smoke-induced emphysema. Grants: Receives NIH funding for studies on fungal asthma pathogenesis (R01 AI135803), miRNA regulation in emphysema (R01 HL140398), and immune mechanisms in allergic inflammation (I01BX004828). Additional VA-ORD support for molecular dissection of miRNAs in asthma. Publications: Over 200 peer-reviewed articles, including landmark studies on platelet-mediated TH2/T17 polarization in fungal immunity, microglia roles in Candida cerebritis, and miRNA-driven TH17 emphysema. Recent work explores SARS-CoV-2 immune responses, long-COVID biomarkers, and antifungal therapies for airway mycosis. Labs/Teams: Leads the Center for Translational Research on Inflammatory Diseases (CTRID) and collaborates with the Baylor Vaccine & Treatment Evaluation Unit. Active in translational research linking immunology discoveries to clinical therapies for allergic, infectious, and autoimmune diseases.

Anneliese Bollandمشاهده پروفایل

دانشیار

• Poverty Studies
• Adolescent Development
• Public Health
• +۵ مورد دیگر

Anneliese Bolland is an Associate Professor in the Department of Communication Studies at the University of Alabama's College of Communication and Information Sciences. Her research focuses on risk and protective factors affecting adolescents in impoverished communities, particularly Black adolescents. She leads the Mobile Youth and Poverty Study (MYPS) and has evaluated projects funded by the National Science Foundation and U.S. Department of Education. Her work spans topics such as mental health disparities, criminal justice system impacts, STEM education equity, and health interventions. She teaches research methods and oral performance courses. Bolland holds a Ph.D. with a dissertation titled Representativeness Two Ways: An Assessment of Representativeness and Missing Data Mechanisms in a Study of an at-risk Population (2012). Recent research trends emphasize marginalized communities, including studies on telehealth access during the pandemic, bioactive interventions for cardiovascular health, and the intersection of racial discrimination and mental health. She has secured grants for longitudinal studies on adolescent development and STEM program efficacy. Bolland collaborates with the Institute for Communication and Information Research and has contributed to policy-oriented analyses of youth delinquency and trauma exposure. Her work addresses systemic inequities through an interdisciplinary lens, blending communication studies, sociology, and public health methodologies. Ongoing projects explore how family and peer environments mediate substance use and academic outcomes among disadvantaged youth.

• Veterinary Sciences
• Animal Nutrition
• Ruminant Nutrition
• +۷ مورد دیگر

Ana Cristina Martins de Miranda Vítor is an Assistant Professor at the Egas Moniz Higher Institute of Health Sciences , where she teaches courses such as Introduction to Animal Organism , Biochemistry and Molecular Biology , and Genetics across Veterinary Medicine and Biomedical Sciences programs. Her academic training includes a Doctorate in Veterinary Sciences (University of Lisbon, 2018–2023) and an Integrated Master's in Veterinary Medicine (University of Lisbon, 2012–2018). Her research focuses on Ruminant Nutrition and Lipid Metabolism , particularly the use of Nannochloropsis oceanica microalgae to protect omega-3 fatty acids from ruminal biohydrogenation. Key projects include GENOCRYPT-Lamb , RumOmics , and Gene2Rumen , funded by institutions like Fundação para a Ciência e a Tecnologia . She employs multi-Omics and metaproteomics to study rumen microbiota interactions and dietary impacts on lamb meat and tissue quality. Her publications explore rumen-protected lipid encapsulation , reticulo-rumen morphology , and omega-3 enrichment in lamb tissues. While no explicit scientific awards are listed, her work is recognized through presentations at conferences like the European Federation of Animal Science Congress and AlgaEurope Congress . She also contributes to teaching and research dissemination via seminars and scientific expeditions.

Georgios Koutsidisمشاهده پروفایل

مدرس ارشد

• Food Chemistry
• Flavour Formation
• Sensory Perception
• +۵ مورد دیگر

Dr Georgios Koutsidis is a Senior Lecturer in Food Science at Northumbria University's Department of Applied Sciences. His research focuses on Food Chemistry, flavor formation, and sensory perception, with notable work on dietary influences on health outcomes, Maillard reaction products, and food safety. He holds a PhD in Flavour Chemistry/Biochemistry from the University of Reading and an MSc in Food Technology. Education PhD in Flavour Chemistry/Biochemistry, University of Reading (2000) MSc in Food Technology (Quality Assurance), University of Reading (1999) Bachelor's in Food Science and Technology, Technical Educational Institution of Thessaloniki, Greece Research Interests Dr Koutsidis explores the intersection of food chemistry and human health, particularly the impact of dietary components on cardiovascular health, gut microbiota, and chronic disease risk. His work integrates analytical chemistry, sensory evaluation, and clinical trials to understand flavor development, toxicant formation (e.g., acrylamide), and the health benefits of functional foods like buckwheat, seaweed, and mycoprotein-based meat substitutes. Advising & Grants Supervised PhD student Julien De Biasi on Maillard reaction products and gut cultures. Active in securing research grants for projects involving food safety, dietary interventions, and nutraceutical development. Key Achievements Published over 30 peer-reviewed articles in high-impact journals like Food Chemistry and PLoS One . Pioneered studies on substituting meat with mycoprotein to reduce genotoxicity and enhance gut microbiota.

• Periodontology
• Oral Microbiology
• Bacterial Adhesion
• +۵ مورد دیگر

Wim Teughels is a Professor at KU Leuven (Faculty of Medicine) and head of the Periodontology & Oral Microbiology research group. He holds visiting professorships at Cukurova University (Turkey) and Malaya University (Malaysia). His expertise spans periodontology, oral microbiology, and biomaterials, with a focus on probiotics, antimicrobials, and biofilm management. He has authored over 200 peer-reviewed articles, 3 books, and serves as associate editor for Journal of Periodontal Research and Carranza's Clinical Periodontology . Education & Qualifications: Dental degree (2000) from Katholieke Universiteit Leuven (KULeuven) Specialist in Periodontology (2006) and PhD (2006), both from KULeuven European Federation of Periodontology (EFP) certificate in Periodontology Research Interests: His work centers on bacterial adhesion, microbial interactions, and novel therapies for oral diseases. Key areas include probiotic delivery systems, antimicrobial biomaterials, and regenerative therapies. Recent projects explore electrospun probiotic encapsulation and zinc-infused polymers for dental implants. Recent Publications Trends: Recent work emphasizes probiotics in oral health, antimicrobial strategies , and biofilm dynamics . Notable contributions include systematic reviews on platelet concentrates in alveolar ridge preservation and consensus reports on periodontal diagnostic technologies. Professional Roles: Co-director, EFP Post-graduate Education Committee Advisor, EAO Consensus Conference Committee ITI University Campus Ambassador Member of multiple academic councils and committees at KU Leuven Labs & Collaborations: Leads the Periodontology & Oral Microbiology research group, collaborating on projects funded by EU grants (e.g., MICROTUNe bioreactor platform) and industry partnerships. Active in developing novel biomaterials and probiotic therapies for peri-implant infections.

• Microbiology
• Infectious Diseases
• Bacterial Pathogenesis
• +۳ مورد دیگر

Gee Lau is a Professor in the Department of Pathobiology at the University of Illinois. His research focuses on microbial pathogenesis, antibiotic development, and host-pathogen interactions, particularly targeting Pseudomonas aeruginosa and Streptococcus pneumoniae. He explores bacterial virulence mechanisms, immune modulation, and novel antimicrobial strategies. Key research areas include: bacterial biofilm formation, genetic competence in pathogens, pyocyanin-induced immune dysregulation, and the design of selective antibiotics that spare gut microbiota. His work bridges microbiology, immunology, and pharmacology, with a strong emphasis on translational applications. Notable projects include developing amphiphilic dendrimers against drug-resistant bacteria, discovering Gram-negative-selective antibiotics, and investigating the role of quorum-sensing inhibitors in disrupting bacterial communication. His research has been widely cited and featured in media for breakthroughs in antibiotic innovation. Collaborations span multiple institutions, focusing on pulmonary infections, sepsis, and chronic bacterial diseases such as cystic fibrosis. Media highlights include coverage of a novel antibiotic that spares gut microbiota and smart implant coatings with antimicrobial properties.

• Molecular Microbiology
• Bacteriology
• Host/Pathogen Interactions
• +۳ مورد دیگر

Dr. Jai Mehat is a Lecturer in Molecular Bacteriology at the University of Surrey’s School of Biosciences. He holds a PhD from the University of Surrey (2017) and specializes in molecular microbiology, bacteriology, and host-pathogen interactions. His research focuses on bacterial pathogen adaptation strategies, particularly in veterinary and medical contexts, combining genomic, genetic, and in vitro/in vivo models to develop non-antibiotic interventions such as vaccines, probiotics, and immune-modulators. Education: PhD in Molecular Bacteriology (University of Surrey, 2017), PGCert, and BSc. Research interests include avian colibacillosis, alternatives to antibiotics, and microbiome roles in livestock health. He leads teaching in the module BMS1035 Practical and Biomedical Bacteriology and supervises ongoing PhD projects on avian pathogenic E. coli evolution and non-antibiotic control strategies. His work spans bacterial genomics, antimicrobial resistance, and rapid diagnostic technologies for infectious diseases, including contributions to the VIDIIA Hunter diagnostic platform approved for UK medical use.

David Gomez Varelaمشاهده پروفایل

پژوهشگر

• Proteomics
• Chronic Pain
• Microbiome Interactions
• +۴ مورد دیگر

Dr. David Gomez Varela is a Senior Scientist at the University of Vienna's Department of Pharmaceutical Sciences, affiliated with the Division of Pharmacology and Toxicology. He holds a permanent position and directs the University of Vienna-Bruker Center of Excellence for Metaproteomics. His roles include leading interdisciplinary projects in proteomics, machine learning, and personalized health solutions. Previously, he worked at UC San Diego and the Max Planck Institute for Experimental Medicine, where he developed novel proteomic techniques like Data Independent Acquisition (DIA). Education: PhD in Biochemistry from Oviedo University (Spain), postdoctoral research in ion channel electrophysiology and microscopy at the Max Planck Institute (Germany), and senior scientist roles in the US and Germany. Research focuses on chronic pain mechanisms, host-microbiome interactions, and microbiome-driven drug discovery. Key projects include CODOP/COEWS algorithms for predicting COVID-19 outcomes and the SaLux pocket PCR machine. Recent publications emphasize proteomic profiling of pain signatures, microbiome interactions, and age/sex differences in neural tissues. Currently leads a team deploying DIA-PASEF mass spectrometry, ML analysis, and mouse behavior studies to identify chronic pain targets. The Center of Excellence for Metaproteomics collaborates with Bruker to advance LC-MS and AI for microbiome studies in health ecosystems. Grants and advising: Directed international teams in pandemic response projects, validated >40,000 patient data. Active in mentoring postdocs and PhD students in proteomics and systems biology. Labs/Teams: Director of the Vienna-Bruker Center, leading the Pharmacology & Toxicology Division's proteomics initiatives. Collaborates globally on translational medicine projects.

Lisa Stinsonمشاهده پروفایل

پژوهشگر ارشد

• Microbiome
• Human Milk Microbiome
• Developmental Origins of Health and Disease (DOHaD)
• +۳ مورد دیگر

Dr. Lisa Stinson is a Research Fellow at The University of Western Australia (School of Molecular Sciences, Centre for Human Lactation Research and Translation). Her research focuses on the early life microbiome, human milk microbiome, and developmental origins of health and disease (DOHaD). She holds a PhD (2019) and Master of Medical Science (2014) from UWA, and a Bachelor of Science from the University of Melbourne (2010). Research Interests: Stinson investigates how the microbiome influences infant health, particularly through maternal milk. Key areas include microbial-based interventions to optimize maternal/infant health, the role of human milk components (e.g., lactoferrin, lysozyme), and the link between early microbiome composition and chronic disease prevention. Her work integrates molecular biology techniques with clinical and epidemiological studies. Grants & Projects: Leads/actively participates in major grants including the WA Breast Milk Biobank (Stan Perron Charitable Foundation), NHMRC-funded microbiome workflow initiatives, and projects examining human milk metabolomics (Medela partnership). Awards: Recognized with ABC’s Top 5 Scientist (2020), School of Molecular Sciences Early-Career Research Award (2023), and multiple best presentation awards (including DOHaD ANZ and ASMR). Her PhD thesis was honored with a Dean’s Award for distinguished work. Labs/Teams: A core member of the Hartmann Human Lactation Research Group, collaborating internationally on microbiome workflows and cohort studies like the BLOSOM project.

• Alcoholic liver disease
• Hepatic stellate cell biology
• TLR4 and TGF-ß signaling in liver pathology
• +۵ مورد دیگر

Hidekazu Tsukamoto, PhD , is a Professor of Pathology at the Keck School of Medicine, University of Southern California, with over 30 years of leadership in alcoholic liver disease (ALD) and liver cancer research. His work spans molecular mechanisms of hepatic stellate cell activation, TLR4/TGF-β signaling, and mitochondrial-epigenetic crosstalk in hepatocarcinogenesis. Institution: University of Southern California Department: Pathology Research Interests : Dr. Tsukamoto’s studies focus on: Epigenetic regulation in liver fibrosis and cancer NOTCH/Wnt signaling in tumor-initiating cells Microbiome-liver axis in ALD Inflammatory pathways in steatohepatitis Metabolic reprogramming of hepatic cells miRNA-based diagnostics and therapies Article Trends : His recent publications emphasize mitochondrial signaling (e.g., ABCB10, NOTCH-TBC1D15 interactions), immune modulation (IL-17, TLR4), and precision animal models (CRISPR-HCC, ethanol infusion systems). Retracted works highlight challenges in reproducibility.